Filing Details
- Accession Number:
- 0001209191-22-013222
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-25 16:54:23
- Reporting Period:
- 2022-02-23
- Accepted Time:
- 2022-02-25 16:54:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1762303 | Avita Medical Inc. | RCEL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250379 | S Michael Perry | C/O Avita Medical, Inc. 28159 Avenue Stanford, Suite 220 Valencia CA 91355 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-23 | 23,753 | $0.00 | 326,564 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-02-23 | 5,960 | $0.00 | 332,524 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-02-24 | 10,812 | $8.74 | 321,712 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2022-02-23 | 3,450 | $0.00 | 3,450 | $12.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,450 | 2022-02-23 | 2031-12-22 | No | 4 | A | Direct |
Footnotes
- These shares of Common Stock were issued upon the vesting of Restricted Stock Units ("RSUs"), which were originally granted on November 26, 2019, in connection with the satisfaction of a performance-based vesting condition.
- Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock.
- Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.
- These shares of Common Stock were issued upon the vesting of RSUs, which were originally granted on December 22, 2021, in connection with the satisfaction of a performance-based vesting condition.
- Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.42 to $8.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.
- These Stock Options were originally granted on December 22, 2021 and vested on February 23, 2022 in connection with the satisfaction of a performance-based vesting condition.
Billionaire Hedge Funds
